Shareholder Alert: Levi & Korsinsky LLP Notifies Investors of Class Action Lawsuit Against –: Business and Professional Services Industry Update
Investigation Commenced into Fairness of Revance Therapeutics Acquisition by Crown Laboratories New York, NY – January 29, 2025 Levi & Korsinsky, LLP announces that it has commenced an investigation into the fairness of the acquisition of Revance Therapeutics Inc (“RVNC” or the “Company”) by Crown Laboratories, Inc. (“Crown”). Background On August 11, 2024, Revance Therapeutics…